{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16629424",
  "DateCompleted": {
    "Year": "2006",
    "Month": "08",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1352-4585",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "2",
        "PubDate": {
          "Year": "2006",
          "Month": "Apr"
        }
      },
      "Title": "Multiple sclerosis (Houndmills, Basingstoke, England)",
      "ISOAbbreviation": "Mult Scler"
    },
    "ArticleTitle": "Treatment of depression for patients with multiple sclerosis in neurology clinics.",
    "Pagination": {
      "StartPage": "204",
      "EndPage": "208",
      "MedlinePgn": "204-8"
    },
    "Abstract": {
      "AbstractText": [
        "The objective of this study was to examine the adequacy of antidepressant pharmacotherapy in a sample of patients with multiple sclerosis (MS) treated by neurologists.",
        "MS patients under the care of neurologists were recruited from a large health maintenance organization. Major depressive disorder (MDD) was diagnosed using a structured telephone interview. Antidepressant treatment data were obtained from the HMO pharmacy database.",
        "Study participants included 260 patients with MS treated by 35 neurologists. A total of 67 (25.8%) patients met the criteria for MDD. Among the patients with MDD, 65.6% received no antidepressant medication, 4.7% received subthreshold doses from their neurologists, 26.6% received doses at threshold, and 3.1% received doses exceeding threshold.",
        "Depression was undertreated by the neurologists treating this sample of patients with comorbid MS and MDD. Potential solutions are discussed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of California, Veterans Administration Medical Center, San Francisco 94121, USA. dmohr@itsa.ucsf.edu"
          }
        ],
        "LastName": "Mohr",
        "ForeName": "D C",
        "Initials": "DC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hart",
        "ForeName": "S L",
        "Initials": "SL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fonareva",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tasch",
        "ForeName": "E S",
        "Initials": "ES"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 MH059708",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 MH059708-06",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "MH59708 R01",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Multicenter Study",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Mult Scler",
    "NlmUniqueID": "9509185",
    "ISSNLinking": "1352-4585"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Nat Clin Pract Neurol. 2006 Oct;2(10):534-5",
      "PMID": "16990825"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospital Departments"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Interviews as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Multiple Sclerosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neurology"
    }
  ]
}